Skip to content

Clinical trials

Rectal Neoplasms trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Not applicable Country / region: China Clear all

119 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20134
20145
20158
201611
20178
20187
20196
20204
202116
20227
202313
202410
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status53
Recruiting26
Completed25
Not yet recruiting5
Withdrawn4
Active, not recruiting3
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University9
Sixth Affiliated Hospital, Sun Yat-sen University9
Sun Yat-sen University7
The First Hospital of Jilin University6
Nanfang Hospital, Southern Medical University5
Ruijin Hospital5
Third Affiliated Hospital, Sun Yat-Sen University5
Southwest Hospital, China4
Third Military Medical University4
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms119
Anastomotic Leak14
Colonic Neoplasms9
Colorectal Neoplasms4
Low Anterior Resection Syndrome4
Stomach Neoplasms4
Liver Neoplasms3
Urinary Retention3
Gastrointestinal Neoplasms2
Neoplasm Metastasis2

Trials

Showing 1 to 25 of 119. Each trial links to its page on Pharma Observatory.

19 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.